Animal models for lead selection against vector borne parasitic diseases within the One Health concept

Abstract

Within OneHealthdrugs we strive to discover new drugs against vector borne diseases with a minimal environmental impact. Animal infection models in combination with a thorough in vitro characterization of potency and selectivity represent indispensable tools for drug discovery.

In the transition from in vitro to in vivo evaluation we adhere to and advocate for the 3R principles (Replacement, Reduction and Refinement). This workshop will therefore cover several aspects of preclinical research in animal models, including principles of 3R and reporting according to the ARRIVE guidelines. As part of the refinement and reduction of animal research, several new imaging technologies have found their introduction in drug discovery for infectious diseases. The workshop also aims to cover some limitations of animal models and to offer a broader perspective beyond mouse models.

The workshop will consist of invited presentations and communications based on abstract selection.

Given the upcoming online WG3 workshop we are launching a call for abstracts within this theme. The deadline for abstract submission is 6th August.

Please find the abstract template in attachment and send it toGuy.Caljon@uantwerpen.be

If you want to register to the meeting, pelase fille the form at the below reported link:

https://docs.google.com/forms/d/e/1FAIpQLScKZMglIuY63O9CgYX37-jjeFemeFFUPi86W7ufMEVIZa7x2Q/viewform?usp=sharing

 

 

Program and abstracts of the WG3 Workshop Animal models for lead selection against vector borne parasitic diseases within the One Health concept

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi